Seòmar agus comataidhean

The second Strategic Transport Projects Review (STPR2) is scheduled for completion and publication later this year.

My intention is to update Parliament with our Winter Resilience plans and publish our Winter Resilience Overview, covering both the NHS and Social Care, early next month, subject to discussions at Parliamentary Bureau. Caroline Lamb, CEO of NHS Scotland has also already written to NHS Boards and Integration Authorities regarding winter resilience plans at a national level and setting out clear expectations for local resilience and response.

Theatre in Schools Scotland is an initiative managed by Imaginate and National Theatre of Scotland (NTS) to develop the provision of theatre and dance performances available for nursery and primary schools to host for their pupils.

In the first three years, fourteen productions toured over six hundred performances to schools and nurseries in every local authority across Scotland. Information on the reach of TISS is available in the following table:

Through subsidy from NTS and Imaginate tickets cost approximated £2 per child. Schools in low-income areas can use their Pupil Equity Funding to pay for access to pay for the TISS programme. The Pupil Equity Funding is allocated directly to schools and targeted at closing the poverty related attainment gap.

In addition, NTS has approached different local trust and foundations to enable free or very low cost performances in economically deprived areas.

The Scottish Government does not hold information on the reasons why people are reportedly using private healthcare.

However, we recognise that addressing the effects of the pandemic has inevitably disrupted the NHS’s ability to carry out routine procedures, meaning longer waits for many patients. We are resuming services as quickly and as safely as possible, while patients who need urgent care, including cancer treatment, are being prioritised.

We recognise the impact long waiting times can have on patients. That is why we have introduced a new set of ambitious targets for NHS Scotland to address the backlog of planned care. Key targets are to eliminate:

• Two-year waits for outpatients in most specialities by the end of August 2022
• 18-month waits for outpatients in most specialities by the end of December 2022
• One-year waits for outpatients in most specialities by the end of March 2023
• Two-year waits for inpatient / daycases in most specialities by the end of September 2022
• 18-month waits for inpatient / daycases in most specialities by the end of September 2023
• One-year waits for inpatient / daycases in most specialities by the end of September 2024

We are working with NHS Boards to maximise capacity to meet these targets and have increased the flexibility Health Boards and clinicians have to manage waiting lists, with a focus on eliminating long waits, as well as continuing to treat the most clinically urgent patients.

The Scottish Government remain absolutely committed to keeping our NHS true to its founding principles – publicly-owned, publicly-operated, and free at the point of need.

The Scottish Medicines Consortium (SMC) is a partner in a UK-wide multi-agency RAPID C-19 initiative, which is a collaborative partnership between the SMC and the National Institute for Health and Care Excellence (NICE). Building on this work, the SMC is exploring the potential for collaboration with NICE on a single technology assessment (STA) of tixagevimab–cilgavimab (Evusheld ® ) for the prevention of COVID-19.

The Robert Gordon University report – Making the Switch, funded through the North-East Economic Recovery and Skills Fund (NEERSF), estimates between 70,000 and 80,000 people are directly and indirectly employed in the offshore energy sector in Scotland, with around 65% working or based in the North East.

This report highlights over 90% of the workforce has medium to high skills transferability between adjacent energy sectors, such as offshore wind, the use of hydrogen and carbon capture and storage. This indicates the North East is well placed to capitalise on the opportunities associated with the energy transition and could become either a UK or Global Energy Hub, with the expected result of the energy workforce remaining broadly stable or increasing by 2030.

The Scottish Government is supporting this transition from the oil and gas sector to renewables and low carbon through a number of programmes, including, but not limited to, the £75 million Energy Transition Fund and our £500 million Just Transition Fund for the North East and Moray.

The Climate Emergency Skills Action Plan is key to ensuring everyone can benefit from the opportunities a Just Transition can create, whether the requirement is to improve on existing skills or retrain to a new or emerging green job.

The application window for the first year of the Just Transition Fund closed on 15 July 2022, with a total of 102 proposals received.

The Fund was advertised through the Scottish Government’s website and social media platforms, as well as through local partners, including: Aberdeenshire Council, Moray Council; Aberdeen City Council; Aberdeen and Grampian Chamber of Commerce; Moray Chamber of Commerce; and the Just Transition Partnership. The Fund was also advertised through the ‘Find Business Support’ portal.

Applicants were notified about the outcome of their proposals on 6 September 2022, but the full list of projects won’t be published until after the mourning period following the passing of Her Majesty The Queen.

Since the introduction of Graduate Apprenticeships (GAs) in Scotland we have seen a positive increase since the first two years of the scheme in the number of individuals taking up the opportunity to study for degree-level courses while in employment.

The following table shows the number of GA starts from 2017.

The Scottish Government has had very constructive discussions with AstraZeneca on Evusheld ® for the preventative treatments for COVID-19. However, throughout the pandemic, a UK-wide approach to the procurement of therapeutics has been taken and has proven vital to allow the UK to have the buying power to secure significant numbers of therapeutics in a competitive global market. A UK-wide approach has also been taken on the development and implementation of clinical prescribing policies for COVID-19 therapeutics. This has ensured patients across the UK have had equal access to safe and effective medicines for COVID-19.

The Scottish Government has not received any requests from the affordable housing supply sector for an early review of benchmarks in accordance with the scenarios envisaged in the Report on the work of the 2021 Affordable Housing Investment Benchmarks Working Group.